Japan’s Ministry of Health, Labor and Welfare approves Medtronic’s (MDT -0.1%) Valiant Navion thoracic stent graft system for the minimally invasive repair of thoracic descending aortic aneurysms and complicated type B aortic dissections (tear in the descending part of the aorta).
Commercial launch is underway.
The device was approved in the U.S. and Europe in late 2018.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.